Aldeyra Therapeutics, Inc.
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
ALDX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US01438T1060
- LEI:
- Country:
- United States of America
- Address:
- 131 HARTWELL AVENUE, 2421 LEXINGTON
- Website:
- https://www.aldeyra.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aldeyra Therapeutics, Inc. is a biotechnology company focused on developing and commercializing medicines to treat immune-mediated diseases. The company's portfolio of product candidates is designed to inhibit inflammatory cells associated with both ocular and systemic ailments, addressing unmet needs where existing treatments are insufficient. Through ongoing clinical trials, Aldeyra is advancing a pipeline of next-generation therapies with the objective of improving patient well-being.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Aldeyra Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aldeyra Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aldeyra Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
